Biomarkers in Colorectal Cancer: Current Research and Future Prospects
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers in Colorectal Cancer: Current Research and Future Prospects
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 15, Pages 5311
Publisher
MDPI AG
Online
2020-07-27
DOI
10.3390/ijms21155311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PVT1 Long Non-coding RNA in Gastrointestinal Cancer
- (2020) Águeda Martínez-Barriocanal et al. Frontiers in Oncology
- Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study
- (2020) Amos Douvdevani et al. Cancer Biomarkers
- Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
- (2020) Christine Koulis et al. Cancers
- lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis
- (2020) Hailu Wu et al. Molecular Therapy-Nucleic Acids
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PVT1 (rs13281615) and miR-146a (rs2910164) polymorphisms affect the prognosis of colon cancer by regulating COX2 expression and cell apoptosis
- (2019) Wanli Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical utility of circulating tumor DNA for colorectal cancer
- (2019) Hiroki Osumi et al. CANCER SCIENCE
- Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC
- (2019) Zhongmiao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Early ctDNA dynamics as a surrogate for progression free survival in advanced breast cancer in the BEECH trial
- (2019) S Hrebien et al. ANNALS OF ONCOLOGY
- Knockdown of long non-coding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p
- (2019) An-Quan Shang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations
- (2019) Natally Horvat et al. EUROPEAN JOURNAL OF RADIOLOGY
- cfDNA for accurate determination of RAS and BRAF mutations using OncoBEAM liquid biopsy in metastatic colorectal cancer patients: Results of the real-world multicentric ColoBEAM study.
- (2019) Alexandre Harle et al. JOURNAL OF CLINICAL ONCOLOGY
- LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer
- (2019) Peizhun Du et al. Journal of Oncology
- Risk prediction models for colorectal cancer incorporating common genetic variants: a systematic review
- (2019) Luke McGeoch et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis
- (2019) Ke Jin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis
- (2019) Ehsan Gharib et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognostic value of long non-coding RNA plasmacytoma variant translocation1 in human solid tumors
- (2019) Bo Zou et al. MEDICINE
- Radiogenomics-based cancer prognosis in colorectal cancer
- (2019) Bogdan Badic et al. Scientific Reports
- Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression
- (2019) Xiang Zeng et al. Cancer Management and Research
- Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
- (2019) Óscar Rapado-González et al. Cancers
- PVT1 Signaling Is a Mediator of Cancer Progression
- (2019) Camille Derderian et al. Frontiers in Oncology
- Long-Chain Noncoding RNA PVT1 Gene Polymorphisms Are Associated with the Risk and Prognosis of Colorectal Cancer in the Han Chinese Population
- (2019) Lei Zhang et al. Genetic Testing and Molecular Biomarkers
- Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions
- (2019) U. Bender et al. Current Oncology
- Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells
- (2019) Gargi Pal et al. Genes
- Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts
- (2019) Gargi Pal et al. PLoS One
- O-027BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti–epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer
- (2018) E Van Cutsem et al. ANNALS OF ONCOLOGY
- Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer
- (2018) Hongliang Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emerging roles of long non-coding RNA in cancer
- (2018) Anna Sanchez Calle et al. CANCER SCIENCE
- Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element
- (2018) Seung Woo Cho et al. CELL
- LncRNA PVT1: a Novel Therapeutic Target for Cancers
- (2018) Xuefeng Pan et al. Clinical Laboratory
- Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
- (2018) Paola Ulivi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells
- (2018) Heng Fan et al. Molecular Medicine Reports
- Upregulated plasmacytoma variant translocation 1 promotes cell proliferation, invasion and metastasis in colorectal cancer
- (2018) Chaoyu Wang et al. Molecular Medicine Reports
- Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives
- (2018) Gianluca Pellino et al. Gastroenterology Research and Practice
- LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy
- (2018) Zhengting Chen et al. Oncology Letters
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Regional variations in UK colorectal cancer screening and mortality
- (2018) Anil Thomas George et al. LANCET
- Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128
- (2018) Feng He et al. ONCOGENE
- Valeur prédictive et pronostique du phénotype MSI dans le cancer du colon non métastatique : qui et comment traiter ?
- (2018) Aziz Zaanan et al. BULLETIN DU CANCER
- Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells
- (2018) Tiejun Song et al. Cancer Biomarkers
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Gene‐environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta‐analyses of observational studies
- (2018) Tian Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b
- (2018) Rui Zhang et al. MEDICAL SCIENCE MONITOR
- Screening of colorectal cancer: present and future
- (2017) Marcello Maida et al. Expert Review of Anticancer Therapy
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
- (2017) Alan P. Venook et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long Noncoding RNA PVT1 Facilitates Cervical Cancer Progression via Negative Regulating of miR-424
- (2017) Ya-Li Gao et al. ONCOLOGY RESEARCH
- The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression
- (2017) Kai Guo et al. TUMOR BIOLOGY
- High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis
- (2017) Qi Huang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells
- (2017) Xian-Wen Zhang et al. Experimental and Therapeutic Medicine
- Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab
- (2017) Wei Cui et al. Oncotarget
- Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
- (2017) Ru Wang et al. Oncotarget
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- An inducible long noncoding RNA amplifies DNA damage signaling
- (2016) Adam M Schmitt et al. NATURE GENETICS
- Kirsten Ras* oncogene: Significance of its discovery in human cancer research
- (2016) Nobuo Tsuchida et al. Oncotarget
- Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases
- (2015) Georgios A. Margonis et al. ANNALS OF SURGICAL ONCOLOGY
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening
- (2015) Takuya Okada et al. CANCER
- LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
- (2015) Wei Peng et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
- (2015) A. Yamada et al. CLINICAL CANCER RESEARCH
- Colorectal cancer screening: a global overview of existing programmes
- (2015) Eline H Schreuders et al. GUT
- Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer
- (2015) Keun Hur et al. GUT
- Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
- (2015) Andrea Wong et al. Journal of Translational Medicine
- In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF V600E in melanoma
- (2015) Xingyi Guo et al. Molecular Cancer
- Unknown
- (2015) Jennifer Hardingham et al. MOLECULAR MEDICINE
- Cell-free circulating tumour DNA as a liquid biopsy in breast cancer
- (2015) Leticia De Mattos-Arruda et al. Molecular Oncology
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Knockdown of long non-coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer
- (2015) XIAO-DONG YANG et al. ONCOLOGY REPORTS
- Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA
- (2015) Nicolas Léveillé et al. Nature Communications
- NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer
- (2015) Yunlong Li et al. Oncotarget
- MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
- (2015) Lina Cekaite et al. Oncotarget
- PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
- (2015) Adeodat Ilboudo et al. International Journal of Environmental Research and Public Health
- Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
- (2014) Y. Y. Juo et al. ANNALS OF ONCOLOGY
- Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
- (2014) Qi Chen et al. Asian Pacific Journal of Cancer Prevention
- HER2/neu testing in primary colorectal carcinoma
- (2014) B Ingold Heppner et al. BRITISH JOURNAL OF CANCER
- Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex
- (2014) Q Ji et al. BRITISH JOURNAL OF CANCER
- miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A
- (2014) Y. Yin et al. CLINICAL CANCER RESEARCH
- Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
- (2014) S. Venderbosch et al. CLINICAL CANCER RESEARCH
- CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
- (2014) Stacey Shiovitz et al. GASTROENTEROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Multitarget Stool DNA Testing for Colorectal-Cancer Screening
- (2014) Thomas F. Imperiale et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA regulons in tumor microenvironment
- (2014) H I Suzuki et al. ONCOGENE
- LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway
- (2014) GUANGYU WANG et al. ONCOLOGY REPORTS
- Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
- (2014) Annamaria Ruzzo et al. Scientific Reports
- Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies
- (2014) H. Brenner et al. BMJ-British Medical Journal
- A Plasma MicroRNA Panel for Detection of Colorectal Adenomas
- (2013) Ziad Kanaan et al. ANNALS OF SURGERY
- Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
- (2013) Jian Zhang et al. ANTI-CANCER DRUGS
- The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
- (2013) V Eklöf et al. BRITISH JOURNAL OF CANCER
- Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
- (2013) Y Takahashi et al. BRITISH JOURNAL OF CANCER
- Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer
- (2013) A. Spreafico et al. CLINICAL CANCER RESEARCH
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of genotype-guided cancer therapy in solid tumors
- (2013) Jai N Patel PHARMACOGENOMICS
- Biomarkers in precision therapy in colorectal cancer
- (2013) M. S. Reimers et al. Gastroenterology Report
- Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
- (2012) Tomoya Yokota Anti-Cancer Agents in Medicinal Chemistry
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- Phosphatase and tensin homolog expression related to cetuximab effects in colorectal cancer patients: A meta-analysis
- (2012) Yue Shen WORLD JOURNAL OF GASTROENTEROLOGY
- European cancer mortality predictions for the year 2011
- (2011) M. Malvezzi et al. ANNALS OF ONCOLOGY
- Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
- (2011) F Thomas et al. BRITISH JOURNAL OF CANCER
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis
- (2011) Long-gang Wang et al. Cancer Epidemiology
- The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
- (2011) Anna Merlos-Suárez et al. Cell Stem Cell
- KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
- (2011) J. Tie et al. CLINICAL CANCER RESEARCH
- p53-dependent Induction ofPVT1and miR-1204
- (2011) Anthony M. Barsotti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras-Mutated Colorectal Cancer
- (2010) J. J. Tentler et al. MOLECULAR CANCER THERAPEUTICS
- Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
- (2009) A. Zaanan et al. ANNALS OF ONCOLOGY
- Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
- (2009) Glenn E Palomaki et al. GENETICS IN MEDICINE
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Caution Is Required Before Recommending Routine Carcinoembryonic Antigen and Imaging Follow-Up for Patients With Early-Stage Colon Cancer
- (2009) Michael Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
- (2009) H. I. Hurwitz et al. ONCOLOGIST
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update
- (2008) Paul Hewitson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
- (2008) E. Lindholm et al. BRITISH JOURNAL OF SURGERY
- The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer
- (2008) Mark Davies et al. Clinical & Translational Oncology
- Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphisms and Toxicity to Capecitabine in Advanced Colorectal Cancer Patients
- (2008) R. Sharma et al. CLINICAL CANCER RESEARCH
- Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
- (2008) A Walther et al. GUT
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started